FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Multiple Sclerosis Booklets Essential to Understanding New Medications











MSology (www.msology.com) is proud to announce the launch of its MS Essentials series, a collection of free publications available for download by people affected by multiple sclerosis (MS). The first three booklets explain the oral medications - Aubagio (teriflunomide), Gilenya (fingolimod), and Tecfidera (dimethyl fumarate) - that are now used to treat MS.

"There are now 10 medications used to treat MS, including the three oral drugs" explains MSology editor Steven Manners. "Each has its own 'personality' - that mix of benefits, side effects and other issues that define a treatment in a person's mind. Choosing the right therapy, one that works and that is easy enough to take every day, can be a real challenge for people. So we thought it would be helpful to explain why a person needs to treat their MS, explain the pros and cons of each drug, and provide some tips to manage side effects and make treatment choices easier."

The MS Essentials series was developed by MSology in collaboration with a team of MS specialist nurses from across Canada. "The nurses' perspective is part of what is essential about the series," Manners says. "They see people every day facing the same challenges - choosing the best medication for their situation, one that they can keep taking to control their MS. Nurses know the practical realities, and they understand the concerns that people have about medications. So, the booklets are able to address those concerns and explain the issues in a very user-friendly way."

Other publications in the MS Essentials series plan to address Lifestyle Issues (diet, exercise, alternative therapies) and New Research.
Since its launch in 2012, MSology has become the world's most-viewed MS website providing new content every week. Editor Steven Manners has been writing about MS for the past 16 years and is the author of the book, Treating Your MS: A User's Guide to Multiple Sclerosis Medications.

To read more about MS, visit the MSology website at www.msology.com. On the site, you can download MS Essentials publications, read all of the posted articles, and sign up for a free subscription to receive regular news updates.

CONTACT INFORMATION
Anne St-Michel
Lind Publishing
+1 (514) 482-9096
astmichel@lindpublishing.com

Story Source: The above story is based on materials provided by MARKETWIRED
Note: Materials may be edited for content and length


Go to Newer News Go to Older News